TD Cowen Reaffirms Their Buy Rating on AstraZeneca (AZN)
TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at ...
TD Cowen Remains a Buy on Ares Management (ARES)
In a report released today, William Katz from TD Cowen maintained a Buy rating on Ares Management (ARES – Research Report), with a price target ...